Indirect comparison of the short-, mid-, and long-term efficacy of treatments for moderate to severe plaque psoriasis: a systematic review and network meta-analysis

Main Article Content

April W Armstrong
Richard B Warren
Yichen Zhong
Joe Zhuo
Allie Cichewicz
Ananth Kadambi
Daniel R Junqueira
Tracy Westley
Renata Kisa
Carolin Daamen
Matthias Augustin


psoriasis, efficacy, meta-analysis, moderate to severe, deucravacitinib, TYK2 inhibitor




1. Guideline on Missing Data in Confirmatory Clinical Trials. European Medicines Agency; 2010. c-guideline/guideline-missing-data-confi rmatory-clinical-trials_en.pdf

2. Guidance for Sponsors, Clinical Investigators, and IRBs. US Food and Drug Administration; 2008.

3. Page MJ, et al. PLoS Med. 2021;18:e1003583.

Most read articles by the same author(s)

1 2 3 4 > >>